Bumper Offer - Urjas oil Just @ Rs. 1
Metolar 25 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of High BP. Secondary and off-label uses of Metolar 25 Mg Tablet have also been mentioned below.
The optimal dosage of Metolar 25 Mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Metolar 25 Mg Tablet include Slow heart rate (pulse). Some other side effects of Metolar 25 Mg Tablet have been listed ahead. Normally, these side effects of Metolar 25 Mg Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
In addition, Metolar 25 Mg Tablet's effect is Severe during pregnancy and Mild for lactating mothers. Warnings related to Metolar 25 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Metolar 25 Mg Tablet is contraindicated in people with pre-existing medical conditions like Bradycardia (Slow Heart Rate) as it can result in adverse effects. Some other conditions that can be affected by Metolar 25 Mg Tablet are listed in the contraindications section below.
Besides this, Metolar 25 Mg Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Metolar 25 Mg Tablet is not safe while driving, and is is not addictive in nature.
Metolar 25 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Metolar 25 Mg Tablet is used -
Moderate
Mild
Common
Is the use of Metolar 25 Mg Tablet safe for pregnant women?
Metolar has many dangerous side effects in pregnant women. If you are pregnant, do not consume Metolar without medical advice.
Is the use of Metolar 25 Mg Tablet safe during breastfeeding?
Metolar may have very limited harmful effects for breastfeeding women.
What is the effect of Metolar 25 Mg Tablet on the Kidneys?
Metolar is completely safe for kidneys.
What is the effect of Metolar 25 Mg Tablet on the Liver?
Metolar is rarely harmful for the liver.
What is the effect of Metolar 25 Mg Tablet on the Heart?
Metolar is rarely harmful for the heart.
Metolar 25 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Metolar 25 Mg Tablet unless your doctor advises you to do so -
Is this Metolar 25 Mg Tablet habit forming or addictive?
Metolar 25 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Metolar 25 Mg Tablet, you should not drive or work on any heavy machine, as Metolar 25 Mg Tablet can make you drowsy.
Is it safe?
Yes, but consume Metolar 25 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
Metolar 25 Mg Tablet is unable to treat or cure mental disorders.
Interaction between Food and Metolar 25 Mg Tablet
When consumed with certain foods, Metolar 25 Mg Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Metolar 25 Mg Tablet
Consumption of alcohol and Metolar 25 Mg Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
